Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Rosty Raykov
1 Sep 2026
Former Director
Sold on a plan
10,000
$12.11
$121.10K
Robert Andrade
27 Aug 2026
Chief Financial Officer
Sold on a plan
75,000
$11.78
$883.50K
Rosty Raykov
3 Aug 2026
Former Director
Sold on a plan
10,000
$9.58
$95.80K
Rosty Raykov
5 Dec 2025
Director
Sold on a plan
10,000
$7.54
$75.40K

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 464,085
History held since 2 May 2007